This vaccine, called Lipo@HEV is the product of combining B16F10, 4T1 and CT26 (epithelial, breast and colon) tumor cell lines with the biocompatible and coadjuvant outer membrane vesicle from Akkermansia muciniphila (Akk-OMV) and loaded with gene therapy plasmid encoding PD-L1 binding domain in a trimeric form that acts as a trap
Science may be on the side of those with other claims
Ceriello A, Novials A, Canivell S, La SL, Pujadas G, Esposito K, Testa R, Bucciarelli L, Rondinelli M, Genovese S
It compared those who used anti-obesity medications, including Wegovy and Zepbound, to those who did not
Endothelial cells exposed to SARS-CoV-2 virus did not exhibit viral replication
Effect of GLP-1 agonists on testosterone levels: a systematic review and meta-analysis